Vance RB - Search Results

1

BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine.

Miller AL, Fehling SC, Vance RB, Chen D, Brown EJ, Hossain MI, Heard EO, Andrabi SA, Wang H, Yang ES, Buchsbaum DJ, van Waardenburg RCAM, Bellis SL, Yoon KJ. Miller AL, et al. Among authors: vance rb. Cancer Lett. 2024 Jun 28;592:216919. doi: 10.1016/j.canlet.2024.216919. Epub 2024 May 3. Cancer Lett. 2024. PMID: 38704133

2

FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.

Kreitzburg KM, Fehling SC, Landen CN, Gamblin TL, Vance RB, Arend RC, Katre AA, Oliver PG, van Waardenburg RCAM, Alvarez RD, Yoon KJ. Kreitzburg KM, et al. Among authors: vance rb. Cancer Lett. 2018 Nov 1;436:75-86. doi: 10.1016/j.canlet.2018.08.015. Epub 2018 Aug 16. Cancer Lett. 2018. PMID: 30120964 Free PMC article.

3

The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma.

Fehling SC, Miller AL, Garcia PL, Vance RB, Yoon KJ. Fehling SC, et al. Among authors: vance rb. Cancer Lett. 2020 Jan 1;468:48-58. doi: 10.1016/j.canlet.2019.10.011. Epub 2019 Oct 9. Cancer Lett. 2020. PMID: 31605774 Free PMC article.

4

Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma.

Miller AL, Garcia PL, Gamblin TL, Vance RB, Yoon KJ. Miller AL, et al. Among authors: vance rb. Cancer Drug Resist. 2020;3(3):572-585. doi: 10.20517/cdr.2020.35. Epub 2020 Aug 7. Cancer Drug Resist. 2020. PMID: 33073205 Free PMC article.

5

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.

Miller AL, Garcia PL, Fehling SC, Gamblin TL, Vance RB, Council LN, Chen D, Yang ES, van Waardenburg RCAM, Yoon KJ. Miller AL, et al. Among authors: vance rb. Cancers (Basel). 2021 Jul 11;13(14):3470. doi: 10.3390/cancers13143470. Cancers (Basel). 2021. PMID: 34298684 Free PMC article.

6

The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models.

Miller AL, Garcia PL, Vance RB, Heard EO, Brown EJ, Yoon KJ. Miller AL, et al. Among authors: vance rb. Cancer Drug Resist. 2024 Oct 18;7:40. doi: 10.20517/cdr.2024.53. eCollection 2024. Cancer Drug Resist. 2024. PMID: 39534870 Free PMC article.

7

Outcomes of cold snare piecemeal EMR for nonampullary small-bowel adenomas larger than 1 cm: a retrospective study.

Dang DT, Suresh S, Vance RB, Singla S, Javia S, Watson A, Chathadi KV, Katukuri V, Pompa R, Stidham RW, Zuchelli T, Piraka C. Dang DT, et al. Among authors: vance rb. Gastrointest Endosc. 2022 Jun;95(6):1176-1182. doi: 10.1016/j.gie.2021.12.018. Epub 2021 Dec 29. Gastrointest Endosc. 2022. PMID: 34971667

8

Gastric Ischemia as a Rare Cause of Hematemesis.

Vance RB, Mayorga CA. Vance RB, et al. ACG Case Rep J. 2017 Jan 4;4:e4. doi: 10.14309/crj.2017.4. eCollection 2017. ACG Case Rep J. 2017. PMID: 28138448 Free PMC article. No abstract available.

9

How Do We Manage Gastric Intestinal Metaplasia? A Survey of Clinical Practice Trends for Gastrointestinal Endoscopists in the United States.

Vance RB Jr, Kubiliun N, Dunbar KB. Vance RB Jr, et al. Dig Dis Sci. 2016 Jul;61(7):1870-8. doi: 10.1007/s10620-016-4107-4. Epub 2016 Mar 17. Dig Dis Sci. 2016. PMID: 26984230

10

Endoscopic options for treatment of dysplasia in Barrett's esophagus.

Vance RB, Dunbar KB. Vance RB, et al. World J Gastrointest Endosc. 2015 Dec 25;7(19):1311-7. doi: 10.4253/wjge.v7.i19.1311. World J Gastrointest Endosc. 2015. PMID: 26722612 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters